All testing provided by the Molecular Pathology Laboratory is accredited by the National Association of Testing Authorities (NATA) Australia. Genetic characterisation enabled by cancer genomics assists clinicians in choosing the most effective therapeutic strategies for individual patients. This personalised take on cancer therapy leads to increased success rates in treatment. The Laboratory, in the Department of Pathology at the Peter Maccallum Cancer Centre, is the premier clinical cancer molecular diagnostic genomics service in Australia.
Molecular Pathology Laboratory services
The facility offers state-of-the-art molecular services on multiple high-throughput test platforms including preparation of RNA, DNA and ctDNA from a large number of specimens for molecular assays, including massively parallel sequencing, Sanger sequencing, fragment analysis and quantitative PCR. The facility works in collaboration with the larger pathology service to provide processing and review of tissue material, assessment of tissue tumour content, and FISH analysis. Our dedicated clinical trials team regularly works in partnership with collaborators to design clinical-grade, tumour-specific assays in small- and large-scale clinical trials.
Molecular Pathology Laboratory accreditation
The laboratory has NATA ISO 15189:2012 accreditation for genetic testing, molecular genetics, DNA sequencing, predictive genetic testing, pharmacogenetic testing, genetic testing for mosaic gene variants (cancer and somatic mosaicism), screening for unknown mutations, assay for defined mutation or polymorphism, massively parallel sequencing, and microsatellite instability.
Molecular Pathology Laboratory contact information
Anthony H. Bell
Principal Scientist
- Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Administration
- Email:
This email address is being protected from spambots. You need JavaScript enabled to view it. - Phone: (03) 8559 5405
- Fax: (03) 8559 5437
Related links
Related pages